Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 43 articles: HTML format

Single Articles

October 2024
1. LOAP P, Kirova Y
   Assessment of Radiotherapy as a Standalone Treatment Following Neoadjuvant Chemotherapy in Nonmetastatic Breast Cancer: A SEER Database Analysis.
   Am J Clin Oncol. 2024 Oct 4. doi: 10.1097/COC.0000000000001146.
   PubMed     Abstract available
   
   
   September 2024
2. QURESHI Z, Jamil A, Fatima E, Altaf F, et al
   Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2- Advanced or Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
   Am J Clin Oncol. 2024 Sep 9. doi: 10.1097/COC.0000000000001143.
   PubMed     Abstract available
   
   
   
3. RITTER AR, Prasad RN, Jhawar SR, Bazan JG, et al
   Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
   Am J Clin Oncol. 2024;47:434-438.
   PubMed     Abstract available
   
   
   
4. NAGAI M, Ewbank H, Po SS, Dasari TW, et al
   Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy: A First-in-Human Randomized Pilot Study. Neuromodulation in Cancer Study (NCAN).
   Am J Clin Oncol. 2024;47:425-430.
   PubMed     Abstract available
   
   
   
5. KIM KW, Lopresti M, Graff SL, Witherby S, et al
   Fulfilling the Role of a Parent While Undergoing Treatment for Cancer: A Review of the Literature and the Potential Impact of Childcare Support on Cancer Outcomes.
   Am J Clin Oncol. 2024;47:445-447.
   PubMed     Abstract available
   
   
   July 2024
6. SANCHEZ-FELICIANO A, Onyewadume L, Stephens MJ, Flores LE, et al
   Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients.
   Am J Clin Oncol. 2024 Jul 26. doi: 10.1097/COC.0000000000001137.
   PubMed     Abstract available
   
   
   
7. BOUZIANE J, Loap P, Cao K, Allali S, et al
   Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the Literature.
   Am J Clin Oncol. 2024 Jul 16. doi: 10.1097/COC.0000000000001135.
   PubMed     Abstract available
   
   
   
8. PUJARI L, Suresh A, Chowdhury Z, Pradhan S, et al
   Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy.
   Am J Clin Oncol. 2024 Jul 4. doi: 10.1097/COC.0000000000001129.
   PubMed     Abstract available
   
   
   
9. QURESHI Z, Altaf F, Jamil A, Siddique R, et al
   Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer: An Updated Systematic Review and Meta-Analysis of Clinical Trials.
   Am J Clin Oncol. 2024 Jul 2. doi: 10.1097/COC.0000000000001126.
   PubMed     Abstract available
   
   
   June 2024
10. QURESHI Z, Jamil A, Fatima E, Altaf F, et al
    Efficacy of Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Comprehensive Systematic Review and Meta-analysis.
    Am J Clin Oncol. 2024 Jun 21. doi: 10.1097/COC.0000000000001121.
    PubMed     Abstract available
    
    
    
11. QURESHI Z, Jamil A, Altaf F, Siddique R, et al
    Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysis.
    Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001120.
    PubMed     Abstract available
    
    
    April 2024
12. NICHOLSON G, Carlson KB, Hernandez RK, Schenfeld J, et al
    Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases: An Analysis of Electronic Health Record Data in the United States From 2014 to 2018.
    Am J Clin Oncol. 2024;47:177-184.
    PubMed     Abstract available
    
    
    March 2024
13. MISTRY T, Nath A, Pal R, Ghosh S, et al
    Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era for the Management of TNBC.
    Am J Clin Oncol. 2024;47:132-148.
    PubMed     Abstract available
    
    
    December 2023
14. NING L, Liu Y, He X, Han R, et al
    Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
    Am J Clin Oncol. 2023 Dec 22. doi: 10.1097/COC.0000000000001080.
    PubMed     Abstract available
    
    
    
15. SHI M, Li Z, Wang T, Wang M, et al
    Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis.
    Am J Clin Oncol. 2023 Dec 15. doi: 10.1097/COC.0000000000001073.
    PubMed     Abstract available
    
    
    
16. MCANDREW EN, Graham J, Dufault B, Desautels DN, et al
    Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in Manitoba.
    Am J Clin Oncol. 2023 Dec 4. doi: 10.1097/COC.0000000000001068.
    PubMed     Abstract available
    
    
    
17. MCMURTRY V, Cleary AS, Ruano AL, Lomo L, et al
    Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
    Am J Clin Oncol. 2023;46:559-566.
    PubMed     Abstract available
    
    
    November 2023
18. MARTINEZ AGUIRRE-BETOLAZA A, Cacicedo J, Castaneda-Babarro A
    Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial.
    Am J Clin Oncol. 2023 Nov 29. doi: 10.1097/COC.0000000000001070.
    PubMed     Abstract available
    
    
    
19. SHAIKH PM, Mulherkar R, Khasawneh MT, Clump D, et al
    Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis.
    Am J Clin Oncol. 2023 Nov 2. doi: 10.1097/COC.0000000000001060.
    PubMed     Abstract available
    
    
    October 2023
20. PAN WK, Ren SY, Zhu LX, Lin BC, et al
    A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Am J Clin Oncol. 2023 Oct 23. doi: 10.1097/COC.0000000000001058.
    PubMed     Abstract available
    
    
    September 2023
21. CHAU B, Loggers ET, Cranmer LD, Mogal H, et al
    Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Am J Clin Oncol. 2023 Sep 19. doi: 10.1097/COC.0000000000001045.
    PubMed     Abstract available
    
    
    August 2023
22. KOPCIK K, Koscielecka K, Krzyzak K
    Cardiac Metastatic Tumors: Current Knowledge.
    Am J Clin Oncol. 2023;46:374-379.
    PubMed     Abstract available
    
    
    July 2023
23. SHUKLA U, Langner UW, Linshaw D, Tan S, et al
    Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy.
    Am J Clin Oncol. 2023 Jul 13. doi: 10.1097/COC.0000000000001028.
    PubMed     Abstract available
    
    
    June 2023
24. FLORES LE, Sargent M, Draeger B, Petereit DG, et al
    Validation of Navigator-Assisted Hypofractionation (NAVAH) Program Survey to Aid American Indian Breast Cancer Patients.
    Am J Clin Oncol. 2023 Jun 9. doi: 10.1097/COC.0000000000001023.
    PubMed    
    
    
    March 2023
25. ABDEL-QADIR H, Thavendiranathan P, Austin PC, Lee DS, et al
    Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 Patients by Benoite M. et al.
    Am J Clin Oncol. 2023;46:129.
    PubMed    
    
    
    
26. ELAYOUBI J, Chi J, Mahmoud AA, Alloghbi A, et al
    A Review of Endocrine Therapy in Early-stage Breast Cancer: The Journey From Crudeness to Precision.
    Am J Clin Oncol. 2023 Mar 1. doi: 10.1097/COC.0000000000000993.
    PubMed     Abstract available
    
    
    January 2023
27. VALENTE M, Chirico I, Girotti C, Ottoboni G, et al
    The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer: A Qualitative Italian Study.
    Am J Clin Oncol. 2023;46:36-42.
    PubMed     Abstract available
    
    
    
28. VICINI F, Livi L, Pignol JP
    The Cost of Simplicity for Early-stage Breast Cancer Treatment.
    Am J Clin Oncol. 2023;46:1.
    PubMed    
    
    
    
29. CAMPBELL SR, Shah CS, Sittenfeld SMC, Hoekstra N, et al
    Five Fraction External Beam Partial Breast Irradiation: A User's Guide.
    Am J Clin Oncol. 2023;46:16-19.
    PubMed     Abstract available
    
    
    
30. CHANG JS, Khan AJ
    Accelerated Partial Breast Irradiation: Technological Advances and Current Challenges.
    Am J Clin Oncol. 2023;46:7-9.
    PubMed     Abstract available
    
    
    
31. MONTALVO SK, Collins B, Vicini F, Rahimi A, et al
    Stereotactic Partial Breast Irradiation: What Does the Future Hold?
    Am J Clin Oncol. 2023;46:20-24.
    PubMed     Abstract available
    
    
    
32. MEATTINI I, Kim K, Livi L
    Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives.
    Am J Clin Oncol. 2023;46:10-15.
    PubMed     Abstract available
    
    
    
33. SHAH C, Leonardi MC
    Accelerated Partial Breast Irradiation: An Opportunity for Therapeutic De-escalation.
    Am J Clin Oncol. 2023;46:2-6.
    PubMed     Abstract available
    
    
    December 2022
34. FAN Y, Pan X, Yang F, Liu S, et al
    Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer.
    Am J Clin Oncol. 2022;45:526-533.
    PubMed     Abstract available
    
    
    November 2022
35. ZHANG ML, Fan YX, Meng R, Cai WK, et al
    Proton Pump Inhibitors and Cancer Risk: An Umbrella Review and Meta-analysis of Observational Studies.
    Am J Clin Oncol. 2022;45:475-485.
    PubMed     Abstract available
    
    
    October 2022
36. ZHOU Q, Zhang Q, Zhao S, Zhang Y, et al
    A Novel Nomogram for Predicting Breast Cancer-specific Survival in Male Patients.
    Am J Clin Oncol. 2022;45:427-437.
    PubMed     Abstract available
    
    
    
37. TUIA JE, Olivier T, Prasad VK
    Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care.
    Am J Clin Oncol. 2022;45:438-441.
    PubMed     Abstract available
    
    
    August 2022
38. LOU J, Kooragayala K, Williams JP, Sandilos G, et al
    The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Am J Clin Oncol. 2022 Aug 19. pii: 00000421-990000000-00030.
    PubMed     Abstract available
    
    
    July 2022
39. KWAPISZ D
    Sacituzumab Govitecan-hziy in Breast Cancer.
    Am J Clin Oncol. 2022;45:279-285.
    PubMed     Abstract available
    
    
    May 2022
40. GARBUIO DC, Ribeiro VDS, Hamamura AC, Faustino A, et al
    A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast: A Double-blinded, Controlled, Randomized, Phase II Clinical Trial.
    Am J Clin Oncol. 2022;45:183-189.
    PubMed     Abstract available
    
    
    April 2022
41. MERY B, Rowinski E, Rivier C, Bouleftour W, et al
    Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 Patients.
    Am J Clin Oncol. 2022;45:155-160.
    PubMed     Abstract available
    
    
    March 2022
42. OLADERU OT, Ma SJ, Miccio JA, Wang K, et al
    Breast and Cervical Cancer Screening Disparities in Transgender People.
    Am J Clin Oncol. 2022;45:116-121.
    PubMed     Abstract available
    
    
    January 2022
43. ARIANI R, Hwang L, Maliglig AM, Ragab O, et al
    Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy: Opportunity for Improved Oligometastases Detection and Salvage Local Therapy.
    Am J Clin Oncol. 2022 Jan 6. pii: 00000421-900000000-98511.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.